ArticleFrontiers in human neuroscience2025
Risk of postoperative major adverse cerebrovascular events in patients with spontaneous intracranial hematoma stratified by type 2 diabetes mellitus.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Diabetes Mellitus (DM) is a common concomitant disease of spontaneous intracranial hemorrhage (ICH). Postoperative major adverse cerebrovascular events (post-MACEs) may diminish the surgical benefits of patients with ICH. However, evidence regarding the impact of DM on post-MACEs remains limited. Methods: This was a multicenter cohort study that enrolled ICH patients presenting to eight neurosurgery departments between January 1, 2015, and May 31, 2021. Patients were categorized into DM group and no diabetes mellitus (nDM) group, based on the presence or absence of DM. Intergroup comparisons were performed using chi-square tests for categorical variables and Mann-Whitney U tests for continuous variables. Multivariate logistic regression analysis was conducted to assess the impact of DM on post-MACEs and 30-days mortality after adjusting for confounding factors. A stratified analysis was also conducted based on the type of post-MACEs. Results: A total of 688 ICH patients were included in the study, of whom 576 (83.7%) were classified into the nDM group and 112 (16.3%) into the DM group. Compared with the nDM group, the DM group exhibited significantly higher incidences of overall post-MACEs (28.6%), ischemic post-MACEs (14.3%), hemorrhagic post-MACEs (23.2%), and 30-days mortality (9.8%). After adjusting for potential confounding factors including sex, age, alcohol, coronary heart disease, dyslipidemia, antiplatelet therapy, and intraventricular hemorrhage, DM remained a significant predictor of overall post-MACEs (OR: 1.790, 95%CI: 1.072-2.990, Conclusion: In conclusion, this study demonstrates that DM serves as a significant risk factor for ischemic post-MACEs, hemorrhagic post-MACEs, and 30-days mortality among patients with ICH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.